A pragmatic diagnostic approach to primary intracranial germ cell tumors and their treatment outcomes.
Jeyaanth VenkatasaiRajesh BalakrishnanBalakrishnan RajkrishnaPatricia SRikki Rorima JohnHarshad Arvind VanjareKrishna PrabhuBijesh NairLeni Grace MathewSelvamani BackianathanPublished in: CNS oncology (2021)
Background: Primary intracranial germ cell tumors (ICGCT) are often diagnosed with tumor markers and imaging, which may avoid the need for a biopsy. An intracranial germ cell tumor with mild elevation of markers is seldom stratified as a distinct entity. Methods: Fifty-nine patients were stratified into three groups: pure germinoma (PG), secreting germinoma (SG) and non-germinomatous germ cell tumors (NGGCTs). Results: At 5 years, progression-free survival and overall survival of the three groups (PG vs SG vs NGGCT) were 91% versus 81% versus 59%, and 100% versus 82% versus 68%, respectively. There was no statistically significant difference in outcome among histologically and clinically diagnosed germinomas. Conclusion: A criterion for clinical diagnosis when a biopsy is not feasible is elucidated, and comparable outcomes were demonstrated with histologically diagnosed germinomas.
Keyphrases
- germ cell
- free survival
- end stage renal disease
- ejection fraction
- high resolution
- newly diagnosed
- chronic kidney disease
- type diabetes
- metabolic syndrome
- clinical trial
- randomized controlled trial
- prognostic factors
- adipose tissue
- peritoneal dialysis
- fine needle aspiration
- mass spectrometry
- fluorescence imaging
- glycemic control
- patient reported